Evidence map›Paper›PMID 37692750›Full record

ReviewCureus2023

A Comprehensive Review of Myocardial Bridging: Exploring Diagnostic and Treatment Modalities.

Endurance O Evbayekha, Enyioma Nwogwugwu, Adedoyin Olawoye, Kafayat Bolaji, Adeyemi A Adeosun, Abimbola O Ajibowo, G Chinenye Nsofor, Vivian N Chukwuma, Hameed O Shittu, Chinwendu A Onuegbu and 2 more

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Article
  3. Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Myocardial Bridging and Cardiac Arrest.JACC. Case reports · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Endurance O EvbayekhaInternal Medicine, St. Luke's Hospital, Chesterfield, USA.
Enyioma NwogwugwuInternal Medicine, Lincoln Medical and Mental Health Center, New York, USA.
Adedoyin OlawoyeInternal Medicine, Maimonides Medical Center, New York, USA.
Kafayat BolajiOphthalmology, Aminu Kano Teaching Hospital, Kano, NGA.
Adeyemi A AdeosunMolecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, USA.
Abimbola O AjibowoInternal Medicine, Lugansk Medical University, Lugansk, UKR.
G Chinenye NsoforInternal Medicine, Buckinghamshire Healthcare NHS Trust, Buckinghamshire, GBR.
Vivian N ChukwumaInternal Medicine, University of Illinois at Chicago/Advocate Christ Medical Center, Chicago, USA.
Hameed O ShittuInternal Medicine, Federal Medical Centre, Abeokuta, NGA.
Chinwendu A OnuegbuInternal Medicine, Montefiore Medical Center, Wakefield Campus, Bronx, USA.
Adewale M AdedoyinInternal Medicine, Lagos State University Teaching Hospital, Ikeja, NGA.
Okelue E OkobiFamily Medicine, Medficient Health Systems, Laurel, USA.
Lincoln Medical Center · USLuhansk State Medical University · UAMaimonides Medical Center · USMayo Clinic · USSt. Luke's Hospital · USVirtua Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial bridging (MB) is a congenital coronary artery anomaly involving an overlying myocardium's partial or complete encasement of a coronary artery segment. The obstruction can lead to significant cardiac symptoms, resulting in myocardial ischemia, arrhythmia, and sudden cardiac death. Several approaches, including invasive and non-invasive methods, have been proposed to diagnose and manage MB. Invasive modalities, such as intravascular ultrasound (IVUS) and coronary angiography, offer high specificity and sensitivity. In contrast, non-invasive methods like Doppler ultrasound, multislice computed tomography (MSCT), and magnetic resonance imaging (MRI) are advantageous due to their non-invasive nature, high sensitivity and specificity, and cost-effectiveness. Treatment options for MB mainly focus on relieving symptoms and preventing adverse outcomes. The use of pharmacological agents and surgical and percutaneous interventions has been documented in numerous studies. Studies conclude that MB is a treatable cardiac anomaly, and a combined approach of diagnosis, treatment, and follow-up is necessary to reduce the morbidity and mortality associated with this condition.

Indexed as

anginaatherosclerosisimagininginterventionsmodalitiesmyocardial bridgemyocardial bridgingmyocardial tunneling

Identifiers

PMID37692750
PMCPMC10484041
OpenAlexW4385664321

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.